ROLE OF MILK IN COGNITIVE FUNCTION AND QUALITY OF LIFE IN OLDER ADULTS WITH MILD COGNITIVE IMPAIRMENT A1 protein free milk may provide enhanced outcomes
With
Dr Emma Beckett,
Food & Nutrition Scientist, FOODiQ Global
Professor Stephen Robinson, Psychology Research
Researcher and corresponding author &
semi-retired neuroscientist, RMIT University
AUSTRALIAN HEALTH JOURNAL SEGMENT
Filmed in Melbourne and Newcastle, NSW | September 2025
New research emphasises the role of cows’ milk, particularly A1 protein free milk, in enhancing cognitive function and quality of life for older adults with mild cognitive impairment (MCI). A multi-centre, double-blinded, randomised controlled clinical study published in *The Journal of Nutrition, Health and Aging* evaluated 88 milk-tolerant Chinese adults aged 65-75 over three months. Participants consumed either ordinary skim milk or A1 protein free skim milk, leading to improvements in various cognitive assessments.
Both types of milk showed significant enhancements in cognitive performance across multiple tests, including the Subtle Cognitive Impairment Test (SCIT), Montreal Cognitive Assessment (MoCA), and Audio Verbal Learning Test (AVLT).
While both groups reported improvements in quality of life, the A1 protein free group noted greater gains, including a 23% increase in overall quality of life scores and a 43% improvement in memory ability. Despite challenges with vitamin D levels among participants, the study highlights the importance of milk choice in promoting cognitive health, especially for the aging population, where approximately 20% of those over 65 may experience MCI.
Researcher and corresponding author of the clinical study, Professor Stephen Robinson spoke to Australian Health Journal about the findings and the need for further research to confirm these benefits across diverse populations.
Dr Emma Beckett, food and nutrition scientist at FOODiQ, says A1PF milk, as part of a balanced diet, can play a valuable role in improving the nutrition of older adults.
“This is an exciting study because it shows that a small dietary change, adding A1PF milk, may be effective for those experiencing cognitive changes. As Australia’s population continues to age, A1PF milk may offer an accessible way to support overall health and wellbeing, particularly in adults living with MCI,” said Dr Beckett.
Source: Adapted from a2 Milk Australia media release and published study
-
World-first clinical trial improves patient outcomes for kidney transplants
A world-first clinical trial conducted at the Royal Adelaide Hospital (RAH) and at hospitals across Australia and New Zealand has identified the best fluid treatment to reduce the risk of patients requiring dialysis after a kidney transplant.
Australian Health Journal spoke with the lead-author of the study, RAH Nephrologist and University of Adelaide researcher, Dr Michael Collins.
-
Continuing education program leads to better conversations
Medicines Australia’s Continuing Education Program (CEP) is designed to educate medical representatives to a recognised industry standard. Dr Tristan Ling, CEP Academic Lead and Project Manager at the College of Health and Medicine, University of Tasmania talks about the 900 students that come through the program each year.
The CEP is primarily directed at medical representatives working within the prescription medicines industry, but is also recommended to people who may not be currently employed within the industry but would like to pursue a career as a medical representative. It is also available to personnel working for organisations interacting with the pharmaceutical industry.
-
Research funded to investigate early-onset bowel cancer progression
Bowel Cancer Australia recently announced a team led by Professor Michael Samuel as the successful applicant for a three-year $600k early-onset bowel cancer research project through the 2023 round of Cancer Australia’s Priority-driven Collaborative Cancer Research Scheme (PdCCRS).
